Results for: generic+drug

FDA approves new type of heart failure drug from Amgen

Walgreens continues pay hike freeze for senior U.S. executives

Jean Coutu shrinks stake in Rite Aid to 11.7 pct

Acquisition boosts Express Scripts profit 39 pct.

FDA lowers age for buyers of Plan B pill to 15

Stocks sink on economic worries Dow off 138

Actavis, Warner Chilcott discussing combination

Earnings Preview: J&J 1Q to focus on newest drugs

Analyst raises shares of Rite Aid to 'outperform'

FDA allows OTC morning-after pill, lifts age limit

Merck climbs after board OKs study continuation

India rejects Bayer plea against cheap cancer drug

Report: Some 2012 prescription spending slipped

NJ drugmaker pleads to criminal charges

Generic drugmaker Akorn's 4Q profit climbs 54 pct

Warner Chilcott 4Q income rises on reduced costs

Europe's financial crisis leads to suicide surge

Key Walgreen revenue metric inches up in March

Report finds big price differences for drugs

AstraZeneca to cut 2,300 jobs in business overhaul

Court: Can drug companies pay to delay generics?

High court struggles over generic drug delay deals

Drugmakers, Interpol ramp up fight against fakes

Pfizer painkiller gets longer patent protection

News Summary: Pfizer painkiller patent extended

New WVU center will do human trials for new drugs

Abbott profit falls on separation costs

Health care among early leaders in the S&P 500

Correction: Pfizer-Antidepressant Suit story

J&J 4Q profit jumps on higher sales, lower charges

Drug safely cuts prostate cancer risk, study finds

Futures modestly higher ahead of Fed meeting

Pfizer 3Q net falls due to generics, higher costs

Futures in holding pattern as Fed gathers

Pharmaceutical giant Teva announces departure of CEO

US, India eye joint efforts against extremist funding

Leaked Asia trade text sees US backing firms

Walgreen fiscal 1Q profit sinks nearly 26 pct

Drug companies forge partnerships with top schools

Indian court to rule on generic drug industry

Drugstore chain Walgreen's 1Q profit jumps 68 pct

Reckitt Benckiser to spin off heroin treatment business

Exclusive: Mylan near multibillion-dollar deal for Abbott drug assets -...

Shire ready to bow to AbbVie's increased $53 billion offer

Pfizer underscores UK commitments in memo